We hope this is the first of many visits to peruse our continuing education options which are being developed to offer you credible, relevant information that you can use to advance your knowledge base and, at the same time, inspire your patients to ask questions and be partners in their own "health" care.

New MOC Program

Improving Remission Rates in Patients With Major Depressive Disorder in an Era of Updated Diagnostic Criteria and Expanding Treatment Options: Application of Tools in the Assessment of Patients With MDD and Initiation of Treatment.
Click here to be directed to the program.
In this activity, an expert in major depressive disorder discusses current guidelines and strategies for the diagnosis and ongoing assessment of patients suffering with this condition. The clinical utility of a variety of therapies is reviewed, along with practical approaches to achieving remission in these patients.        
The Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This CME activity is jointly provided by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education, who is hosting this session.